Relationship between Atherogenic Dyslipidaemia and Lipid Triad with Different Scales of Overweight and Obesity in 418,343 Spanish Workers

Carla Busquets-Cortés; Carlos López; Hernán Paublini; Sebastiana Arroyo Bote; Ángel Arturo López-González; José Ignacio Ramírez-Manent

doi:10.1155/2022/9946255

Relationship between Atherogenic Dyslipidaemia and Lipid Triad with Different Scales of Overweight and Obesity in 418,343 Spanish Workers

J Nutr Metab. 2022 Aug 9:2022:9946255. doi: 10.1155/2022/9946255. eCollection 2022.

Authors

Carla Busquets-Cortés¹, Carlos López¹, Hernán Paublini¹, Sebastiana Arroyo Bote¹, Ángel Arturo López-González^{1

2}, José Ignacio Ramírez-Manent^{3

4}

Affiliations

¹ ADEMA University School, Carrer de Passamaners 11, Palma 07009, Balearic Islands, Spain.
² Prevention of Occupational Risks in Health Services, Balearic Islands Health Service, Palma, Spain.
³ Balearic Islands Health Service, Family Medicine, Calvià, Spain.
⁴ Faculty of Medicine, University of the Balearic Islands, Palma, Spain.

Abstract

Obesity induces alterations in lipid biochemistry, evolving toward dyslipidaemia atherogenesis, a critical factor in the development of cardiovascular events. Two relevant forms of lipid abnormalities are atherogenic dyslipidaemia (AD) and lipid triad (LT), which involve alterations in triglyceride levels, HDL-c, and LDL-c. The aim of this study was to assess the linkage of atherogenic AD and LT with different scales of overweight and obesity. We carried out a cross-sectional study including 418,343 Spanish adult workers, recruited from workplace health assessments. Atherogenic dyslipidaemia was defined as triglyceride levels ≥ 150 mg/dL, HDL values < 40 mg/dL in men and <45 mg/dL in women, and normal LDL. Additionally, if LDL levels were >160 mg/dL, LT was considered. Subjects affected by AD and LT in the study exhibited significantly higher mean values than those without AD and LT in all overweight, obesity, and body fat related scales studied. VAI (visceral adiposity index) was the strongest predictor of AD (AUC = 0.934, 95% CI: 0.933 to 0.936) and LT (AUC = 0.926, 95% CI: 0.923 to 0.928). Atherogenic dyslipidaemia and LT positively correlate with different scales of overweight and obesity. Further studies should aim to identify other contributory factors. Our obtained data might be useful in laying the groundwork for future works on AD and LT.